圭亚那：2020年基本药物清单（英文）

GUYANA ESSENTIALMEDICINES LIST 2020-2022 Preface Acknowledgementsiv Introductionv Guyana Essential Medicines List1 PREFACE The goal of the Ministry of Public Health (MOPH) of Guyana is for people in Guyana to be amongthe healthiest in the region of the Americas. Achievement of this goal hinges on a multi-facetedapproach to provide access to high-quality health care services throughout the country. To this Over the years, the Government has invested increasing amounts of resources (technical,financial, human), to ensure the availability of quality medicines at all levels of the health caresystem.Additionally,the Ministry has developed standard guidelines and protocols andimplemented training of health professionals to ensure that when treatment is administered, this Further, the Ministry has fully embraced the World Health Organization’s essential medicinesconcept, which defines essential medicines as those that satisfy the priority health care needs of The Ministry with the expert assistance of the Pan American Health Organization/World HealthOrganization (PAHO/WHO) and University Center of Pharmacology (CUFAR) National Universityof La Plata- School of Medicine (PAHO /WHO Collaborating Center), and under the leadership ofthe National Medicines Policy Committee and Mr. Oneil Atkins Director, National Pharmacy This GEML is a national standard document which serves to guide all healthcare practitioners inthe selection, procurement, stocking and utilisation of the safest and most efficacious medicinesneeded to ensure good health of all. Therefore, I recommend this document and look forward to ACKNOWLEDGEMENTS This edition of theGuyana Essential Medicines List(GEML) was made possible through theexceptional contributions of many persons. Sincere gratitude is therefore extended to all who Special acknowledgement is made of the Minister of Public Health, Honourable Volda Lawrence,for the vision of making Guyanese among the healthiest citizens of the region of the Americasand for the leadership exemplified for its execution. Appreciation is also extended to Dr. Shamdeo Recognition and gratitude are also extended to the Pan American Health Organization/ WorldHealth Organization(PAHO/ WHO) and University Center of Pharmacology (CUFAR), National Appreciation is also made for the continual consultative efforts of the core members of the GEML Finally, sincerest thanks are extended to the staff of National Pharmacy Services, as well as thefollowing persons for their assiduous efforts towards preparation and completion of the GEML: ❖Mr. Lee Van De Santos–Deputy Director of Pharmacy Services❖Ms. Stacy James–Senior Pharmacist, National Pharmacy Services❖Dr. Kishore Ramdass–Head of Pharmaceutics and Therapeutics Committee, GPHC Pan American Health Organization/ World Health Organization (PAHO/ WHO) ❖Dr. William Adu-Krow–PAHO/WHO Representative, Guyana❖Dr. Paul Edwards–Advisor Health Systems and Services, PAHO/WHO, Guyana ❖Ms. Gomattie Dath–National PAHO Consultant, Pharmacy, PAHO/WHO, Guyana Mr. Oneil AtkinsNational Director of Pharmacy Services INTRODUCTION Guyana’s Essential Medicines List (GEML) consists of a group of core medicines that werechosen within the local context of public health relevance and to satisfy the priority medical needsofthe population.The development of this list followed multiple consultations with keystakeholders which took into account Guyana’s epidemiologic profile, data on safety, efficacy and The GEML is a reference list of medicines. It will serve as a standard for procuring medicines forthe public sector and will, therefore, be used as a mandatory guide to prescribers, pharmacists Prescribers should not disregard their therapeutic judgment nor should patients their preferenceto use other treatment options outside of the GEML. However, strong evidence in support ofsuperior benefits or advantages of the alternate options to the patient; along with considerations It should be noted that information necessary to the use of these medicines such as indications,contraindications, safety, doses, etc. are not included on the GEML, but they will be found on the Benefits of the GEML The use of the GEML is expected to improve medicines availability, prevent irrational use ofavailable medicines and prevent the presence of medicines that are of poor quality in the publicsector. It will also foster evidence-based use of medicines and promote cost justification for Addition and Deletion on the GEML The list would be updated every two years by the EML committee in conjunction with the NationalMedicinesand Therapeutic Committee (NMTC).All requests for new medicines must be accompanied by supportingdata (specific indication,public health relevance of medicine,availabilityof pharmacopoeia standards,international availability of medicine,comparative The form/ tool designed by the EML committee is to be employed for addition and deletion. Used in the text: ADRsAdverse Drug Reactio